Home > Quotes > GSK > Company News

GlaxoSmithKline PLC News Headlines

GSK 
$52.21
*  
0.01
  negative  
0.02%
Get GSK Alerts
*Delayed - data as of May 20, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

The Billion Dollar COPD Deal: Who Gains The Most?
5/17/2013 11:27:00 AM - Seeking Alpha

Complete Warren Buffett And Berkshire Hathaway 1st Quarter Portfolio Update
5/16/2013 2:04:00 PM - Seeking Alpha

Time To Show Optimism For Stocks
5/16/2013 1:57:00 PM - Seeking Alpha

Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q1 2013 Update
5/16/2013 7:06:00 AM - Seeking Alpha

Amicus Therapeutics: The Good And The Bad
5/15/2013 1:31:00 PM - Seeking Alpha

Aveo Screwed Up but Its Kidney Cancer Drug Is Real
5/15/2013 9:24:00 AM - TheStreet

3 Pharmaceuticals For Attractive Dividends
5/15/2013 7:55:00 AM - Seeking Alpha

Elan in Royalty Deal with THRX - Analyst Blog
5/14/2013 5:06:44 PM - Zacks.com

Wider-than-Expected Loss at ChemoCentryx - Analyst Blog
5/14/2013 10:55:01 AM - Zacks.com

ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding
5/13/2013 10:08:00 PM - RTT News

2ND UPDATE: C.R. Bard to Pay $48.3 Million to Settle Kickback Case -DOJ
5/13/2013 7:22:00 PM - Dow Jones Business News

Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog
5/13/2013 6:06:31 PM - Zacks.com

Elan Strikes $1 Bln Royalty Deal With Theravance
5/13/2013 11:06:00 AM - RTT News

Invest In Greece Because The Turnaround Has Already Started
5/13/2013 9:06:00 AM - Seeking Alpha

Elan Signs $1 Billion Drug Deal with Theravance
5/13/2013 5:45:00 AM - Dow Jones Business News

Elan Signs $1 Billion Drug Deal
5/13/2013 5:45:00 AM - Dow Jones Business News

Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact
5/13/2013 2:34:00 AM - Dow Jones Business News

Elan And Theravance Reach $1.0 Bln Royalty Participation Deal - Quick Facts
5/13/2013 2:16:00 AM - RTT News

European Stocks Seen Subdued As Commodities Slide
5/13/2013 2:13:00 AM - RTT News

Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:06:00 PM - Seeking Alpha

FDA Okays Theravance, Glaxo Drug To Treat COPD - Update
5/10/2013 2:48:00 PM - RTT News

UPDATE: FDA Approves GlaxoSmithKline's Breo Ellipta to Treat Lung Disease
5/10/2013 2:33:00 PM - Dow Jones Business News

GlaxoSmithKline's Breo Ellipta Receives FDA Approval To Treat Lung Disease
5/10/2013 1:02:00 PM - RTT News

GSK, Theravance See Breo Ellipta Available in 3Q13 After FDA Approval
5/10/2013 12:27:00 PM - Dow Jones Business News

FDA OKs GlaxoSmithKline Drug to Treat Lung Disease
5/10/2013 12:15:00 PM - Dow Jones Business News